Miegueu P, Cianflone K, Richard D, St-Pierre DH. Motilin stimulates preadipocyte proliferation and differentiation and adipocyte lipid storage. Am J Physiol Endocrinol Metab 301: E758-E766, 2011. First published July 19, 2011 doi:10.1152/ajpendo.00089.2011Motilin is a circulating gastrointestinal peptide secreted primarily by duodenal mucosal M cells and recognized for its prokinetic effects on gastrointestinal tissues. Little information is available regarding effects on insulin/glucose homeostasis or adipocyte function. Our aim was to evaluate the effects of motilin on adipocyte proliferation, differentiation, lipolysis, and macronutrient uptake in adipocytes. 3T3-L1 cells and primary rat adipocytes were treated acutely and chronically with varying motilin concentrations, and effects were compared with vehicle alone (control), set as 100% for all assays. In preadipocytes, motilin stimulated proliferation ([ 3 H]thymidine incorporation) and mitochondrial activity (141 Ϯ 10%, P Ͻ 0.001 and 158 Ϯ 10%, respectively, P Ͻ 0.001), in a concentration-dependent manner. Chronic supplementation with motilin during differentiation further increased lipogenesis (Oil red O staining 191 Ϯ 27%, P Ͻ 0.05) and was associated with an upregulation of PPAR␥ (148 Ϯ 8%, P Ͻ 0.01), C/EBP␣ (142 Ϯ 17%, P Ͻ 0.05), and Cav3 (166 Ϯ 20%, P Ͻ 0.05) expression. In mature 3T3-L1 adipocytes motilin increased fatty acid uptake/incorporation (Յ202 Ϯ 12%; P Ͻ 0.01) and glucose uptake (146 Ϯ 9% P Ͻ 0.05) and decreased net fatty acid release (maximal Ϫ31%, P Ͻ 0.05) without influencing total lipolysis (glycerol release). Similar effects were obtained in primary rat adipocytes. Motilin acutely increased expression of PPAR␥, CEBP␤, DGAT1, and CD36 while decreasing adiponectin mRNA and secretion. In human adipose tissue, motilin receptor GPR38 correlated with HOMA-IR and GHSR1 (r ϭ 0.876, P Ͻ 0.0001). Motilin binding and fatty acid incorporation into adipocytes were inhibited by antagonists MB10 and [D-lys3]-GRP6 and PI 3-kinase inhibitor wortmannin. Taken together, these results suggest that motilin may directly influence adipocyte functions by stimulating energy storage. gastrointestinal hormones; peroxisome proliferator-activated receptor-␥; gene expression STRONG EVIDENCE SUGGESTS the neuroendocrine nature of many gastrointestinal (GI) peptides and their relevance in the regulation of important biological functions such as energy balance. The discovery of ghrelin in 1999 (18) provided evidence that a specific GI peptide could stimulate growth hormone secretion and appetite centrally besides influencing gut motility, glucose metabolism, adipogenesis, inflammation, and cardiovascular functions in the periphery (42). In contrast to ghrelin, there is limited information available regarding "long-discovered" GI peptides and their influence on the regulation of metabolic functions. Isolated and characterized in 1971, motilin is predominantly recognized for its prokinetic effects on gastric motility and emptying (5). Interestingly, motilin and ghrelin share important amino acid sequence homologies at the level of their precursor (almost 50%), circulating peptides (21%), and their respective receptors (53%) G protein-coupled receptor (GPR)38 and GH secretagogue receptor (GHSR)1a (32).
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Motilin is a 22-amino acid (aa) peptide predominantly secreted by the M cells of the duodenojejunal mucosa. It is released in 90-to 120-min cycles during the interdigestive period to stimulate gastric motility and emptying by activating the third phase of the migrating motor complex (17) . While GPR38 was cloned as an orphan receptor in 1997, motilin was identified as its endogenous ligand only in 1999 (25) . In human and animal (mainly rabbit and pig) models, GPR38 is expressed in the smooth muscle layer and the mucosa of the GI tract, the amygdala, the mesenteric neurons, and the hippocampus (21, 40, 41, 49) . In mice, it is presently debated whether or not the motilin receptor is truly expressed or is simply present as a pseudogene (15) . Meanwhile, direct motilin injection or administration of GPR38 agonists and antagonists were shown to induce biological effects in rodents (2, 36) . These elements suggest that such effects are mediated through the activation of GPR38 or another receptor in murine models.
It is presently debated whether motilin levels are positively or negatively influenced by fasting (28) or food intake in patients with obesity, hyperinsulinemia, hyperglycemia, and type 1 or 2 diabetes (3, 29, 30) . Increased motilin levels were observed in morbidly obese patients, whereas gastric surgeryinduced weight loss normalized motilin concentration (7, 46) . On the other hand, no significant differences in motilin levels were detected in obese diabetic mice vs. controls (11) .
Evidence suggests that motilin and motilin receptor GPR38 are expressed in the brain, and central administrations of motilin increased both appetite in mice (1) and satiety perception in healthy human subjects (9) . Postprandially, evidence suggests that the levels/effects of motilin are influenced by the texture and macronutrient composition of an ingested meal (6) . More specifically, in normal subjects, motilin levels were shown to increase following a lipid infusion (34) and to decrease after a glucose tolerance test (14) . In a canine model, acute administration of motilin induced insulin secretion without altering glucose levels (38) . In patients with type 2 diabetes, erythromycin, a motilin agonist, stimulated insulin secretion, decreased glucose, and improved basal and glucosestimulated insulin secretion when administrated orally for 4 wk (43) . Taken together, these elements indicate that motilin could be considered one of the numerous factors involved in longterm regulation of energy storage.
On the basis of 1) the fact that motilin and ghrelin are colocalized and cosecreted from a prominent endocrine cell population (48) , 2) the significant sequence homologies between motilin and its receptor GPR38 with ghrelin and its receptor GHSR1, 3) the recent demonstration of ghrelin effects on key adipocyte functions such as proliferation, differentiation and glucose uptake (24) , and 4) preliminary data supporting a broader function for motilin in insulin-glucose homeostasis and energy metabolism as described above, we hypothesized that motilin might also directly influence adipose tissue functions. Therefore, the present study was designed to investigate the effect of motilin on proliferation and mitochondrial activity in preadipocytes, adipocyte differentiation, and glucose/fatty acid metabolism in mature adipocytes.
MATERIALS AND METHODS

Reagents
Insulin-like growth factor I (IGF-I), insulin, and the ghrelin receptor GHSR1 antagonist [D-lys3]-GRP6 were purchased from SigmaAldrich (Oakville, ON, Canada). 2-(4,5-dimethyl-2-thiazolyl)-3-(4-sulfophenyl) (MTS) was obtained from Promega (Madison, WI). DMEM-F12, phosphate-buffered saline (PBS), bovine calf serum (BCS), and fetal bovine serum (FBS) were supplied by GIBCO (Burlington, ON, Canada). Isobutylmethylxanthine (IBMX), dexamethasone, penicillin-streptomycin, and trypsin were from Life Technologies (Carlsbad, CA), 2-deoxy-D- [1- 3 H]glucose, and [ 3 H]thymidine were purchased from GE Healthcare (Montreal, QC, Canada). Motilin (human/porcine sequence), and motilin 1-12 [CH2 NH]9 -10 (MB10), a motilin antagonist, were generously provided by Peptidec Technologies (Montreal, QC, Canada).
125
I-labeled motilin and [methyl-3 H]thymidine were from PerkinElmer. Peptide purity (Ͼ95%) and identity were confirmed by analytic RP-HPLC using a C18 3-m column and by LC-MS. Concentrated peptide solutions (1 mg/ml) were prepared in PBS and stored as 20-l aliquots in Eppendorf vials at Ϫ80°C until use. Motilin concentrations used had previously been shown to elicit a response in vitro (10, 28) .
Cell Culture of 3T3-L1 Preadipocytes and Standard Differentiation into Mature Adipocytes
Murine preadipocyte (3T3-L1) cells were purchased from the American Type Culture Collection (Manassas, VA). Preadipocytes were cultured using DMEM-F12 supplemented with 10% BCS medium and kept at 37°C in a 5% CO 2 incubator. Experiments were performed when the cells were at low passage number and were routinely subdivided at Ͻ70% confluence.
For standard 3T3-L1 adipocyte differentiation, preadipocytes were seeded in 48-well culture plates (1.5 ϫ 10 4 cells/well) and grown to confluence. A 2-day postconfluence differentiation was initiated with medium containing 1.721 M insulin, 1 M dexamethasone, and 0.5 mM IBMX in DMEM-F12 with 10% FBS. Two days later, medium was replaced with DMEM-F12 containing 10% FBS and 1.721 M insulin. Another 2 days later, medium was changed to DMEM-F12 plus 10% FBS. Differentiated cells (Ն90% with lipid droplet accumulation) were used for functional and binding assays (as described below) on days 8 -9 after differentiation was initiated.
Rat and Human Adipose Tissue and Isolation of Primary Rat Adipocytes
Nine-week-old, 250-g male Sprague-Dawley (SD) rats (Charles River Laboratories) were randomly divided into two groups. All experiments were conducted in accordance with the Laval University Guide for the Care and Use of Laboratory Animals. Animals were fed a standard chow diet ad libitum. After euthanasia, retroperitoneal and epididymal fat pads were immediately placed in Krebs's Ringer buffer (KRB), pH 7.4. Adipose tissues were rinsed with fresh KRB, and fibrous tissue and blood vessels were carefully dissected and removed. The remaining tissues were minced into small pieces (and used directly for lipolysis assays) or digested with 0.25% collagenase and 2% BSA for 45 min at 37°C under continuous shaking. The dispersed tissue was filtered through a nylon mesh sheet (pore size 250 m) and centrifuged to obtain floating primary mature adipocytes. Human adipose tissues were obtained at a time of bariatric surgery as described previously (22, 23) , and gene expression data are reported in GEO profiles.
Effect of Motilin on Preadipocyte Functions
Preadipocyte proliferation. Preadipocyte proliferation was evaluated according to Boney et al. (4) . Cells were seeded (1 ϫ 10 4 cells/well) on a 48-well plate. The next day, cells were incubated in serum-free DMEM-F12 for 2 h, treated with the indicated reagents for 24 h at 37°C, and then incubated with [ 3 H]thymidine for 15 h at 37°C. After removal of the labeling solution, cells were rinsed three times with cold PBS and solubilized in 0.3 N NaOH (250 l) for 3h; a 50-l aliquot was set aside for protein assay by a Bradford assay (Bio-Rad, Mississauga, ON, Canada). Trichloroacetic acid (50 l, 20% vol/vol solution) was added, the lysate incubated for 30 min at room temperature and centrifuged, and the supernatant counted by liquid scintillation.
Mitochondrial activity in preadipocytes. Mitochondrial activity was evaluated using the Cell Titer 96 Aqueous One Solution (Promega) as described by the manufacturer. The MTS assay is a colorimetric assay containing a tetrazolium compound, which, when bioreduced by NADPH or NADH (produced by dehydrogenase enzymes), produces formazan, an end product with colorimetric properties, The assay can be used to evaluate mitochondrial metabolic activity, proliferation, cytotoxicity, or viability. 3T3-L1 preadipocytes (5 ϫ 10 3 cells/well) were plated in 96-well culture plates. Cells were then transferred to serum-free DMEM-F12 for 2 h (75 l) and treated with the indicated reagents for 24 h at 37°C. MTS (20 l) was added and the solution incubated for 3 h at 37°C. Absorbance at 490 nm signaling formazan production, an indicator of mitochondrial activity, was normalized per microgram of cell protein.
Effect of Motilin on 3T3-L1 Adipocyte Differentiation
The effect of motilin on 3T3-L1 differentiation was evaluated using a modification of the procedure described above. Two-day postconfluent preadipocytes were treated with a standard differentiation medium (1.721 M insulin, 1 M dexamethasone, and 0.5 mM IBMX in DMEM-F12 with 10% FBS) supplemented with motilin (at the indicated concentrations) for 3 days. The medium was then changed to DMEM-F12 and 10% FBS with 1.721 M insulin plus the same supplements (additional motilin) for a further 3 days. Finally, the medium was changed to DMEM-F12 and 10% FBS with/without additional motilin supplements for 3 days. On day 9, 3T3-L1 mature adipocytes were processed for lipid staining or gene expression. For lipid staining, cells were washed with PBS, fixed with 10% formalin for 30 min, and stained for 1 h at room temperature in freshly diluted Oil red O solution. Cells were rinsed three times with PBS, and stained lipids were visually assessed by microscopy. For quantitative analysis of Oil red O, stained lipids were extracted with 200 l of heptane-isopropanol (3:2) overnight at 4°C; absorbance was then measured at 540 nm and normalized per microgram of cell protein.
For gene expression analysis on day 9, cells were washed with PBS and immediately stored at Ϫ80°C for RNA extraction and analyzed as described below.
Effect of Motilin on Mature Adipocyte Functions
Fatty acid uptake and incorporation. Mature adipocytes (3T3-L1 and primary rat adipocytes) were preincubated for 2 h in serum-free DMEM-F12 and then treated with hormones for 1 h (200 l, in serum-free DMEM-F12). In experiments using antagonists or inhibitors, cells were pretreated with these substances for 30 min before treatment with motilin. Fatty acid uptake and incorporation were evaluated in the constant presence of the hormones by using a QBT fluorescent fatty acid (FA) assay kit (Molecular Devices, Sunnyvale, CA) performed according to the manufacturer's instructions with minor modifications. As previously described (8), BODIPY reagent (200 l, diluted in 0.2% BSA in Hank's balanced salt solution) was added directly to the incubation medium containing the cells and BODIPY-FA uptake was measured in real time every 20 s over 120 min in a bottom-reading fluorescent microplate reader (Synergy HT, Biotek). Following measurement of BODIPY-FA uptake, solutions were removed and cells washed twice gently with cold PBS; neutral lipids were then extracted with 200 l of heptane-isopropanol (3:2) overnight at 4°C and rinsed with an additional 500 l of the same solvent. Lipid extracts were evaporated to dryness in a centrifugeevaporator (Canberra-Packard Canada) and redissolved in 50 l of heptane-isopropanol (3:2). Triglyceride mass was measured using an enzymatic colorimetric assay (Roche Diagnostics, Indianapolis, IN). Incremental area under the curve (IAUC) of FA incorporation into adipocytes was evaluated by the trapezoidal method (GraphPad Prism Software, San Diego, CA) and normalized to cell triglyceride mass.
Glucose transport in 3T3-L1 adipocytes. 3T3-L1 adipocytes were preincubated for 2 h in serum-free DMEM-F12 and treated with hormones at the indicated concentrations for 1 h (200 l, in serumfree DMEM-F12). Glucose transport assays were performed as previously described (47) . Following prestimulation, adipose cells were rinsed with warm (37°C) PBS, and glucose-free DMEM was added and incubated with 2-deoxy- [ 3 H]glucose (50 mol/l, final specific activity 60 -190 dpm/pmol) in serum-free, glucose-free medium at 37°C for exactly 10 min.. For these experiments, 0-min 2-deoxy-[ 3 H]glucose values were considered as background and used to correct values evaluated at other time points. Following incubation, the glucose uptake was rapidly stopped by washing the cells with cold PBS and dissolving them with 1 N NaOH. Aliquots were collected and glucose uptake values evaluated by scintillation counting. Protein levels used to normalize were evaluated by means of the Bradford assay (Bio-Rad).
Lipolysis. Mature 3T3-L1 adipocytes or adipose tissue were preincubated in serum-free medium for 2 h and then treated with the indicated hormones for 3 h. The medium was collected and centrifuged, and the supernatant was frozen at Ϫ80°C. Nonesterified FAs (NEFA) and glycerol concentrations were measured using colorimetric enzyme assays (Wako, Osaka, Japan, and Roche Diagnostics, Indianapolis, IN, respectively). Glycerol and NEFA concentrations were normalized per nanomole of cell triglyceride mass or milligram of protein tissue.
Adiponectin measurement. Following standard differentiation, mature 3T3-L1 adipocytes were preincubated in serum-free medium for 2 h and then treated with the indicated hormones for 24 h. The cell culture medium was collected and adiponectin level quantified using a mouse adiponectin radioimmunoassay kit as described by the manufacturer (Linco, Millipore USA).
Motilin binding and competition assays. Mature 3T3-L1 adipocytes were preincubated in serum-free medium for 2 h and the cell culture medium was carefully aspirated. Direct binding studies were performed with increasing concentrations of motilin. Competition assays were performed with addition of increasing concentrations of competitors (10 Ϫ9 to 10 Ϫ5 M) with a fixed concentration of 125 I-motilin (100 nM) for 120 min at room temperature. The reaction was stopped by placing on ice, the medium was aspirated, cells were washed twice with cold PBS, and cells were lysed with 1 N NaOH with constant shaking for 1 h. The cell lysates were collected and then counted. Nonlinear regression analysis for one-site binding was used to evaluate binding parameters using GraphPad Prism 4.0 software (San Diego, CA).
RT-PCR Assays
RNA extraction and real-time quantitative RT-PCR. For human adipose tissue, RNA extraction and microarray analysis were as described in detail previously (22, 23) . For 3T3-L1 mature adipocytes, total RNA was extracted from acutely (24 h) and chronically (9 days) treated-3T3-L1 adipocytes using an RNeasy Mini Kit and a onecolumn DNase treatment according to the manufacturer's specifications (Qiagen). Total RNA samples of 1 g were converted to cDNA with random primers in a total volume of 10 l. Prevention of genomic DNA contamination was achieved by using the RT 2 First Strand Kit (SABiosciences, Frederick, MD). Real-time qRT-PCR array analyses were performed in 96-well plates of a Custom Mouse RT 2 Profiler PCR Array, which contained mouse genomic DNA contamination (MGDC) and reverse transcription control (RTC). The array was designed to simultaneously quantify mRNA expression of the indicated and housekeeping genes (SABiosciences). Briefly, reactions were achieved in triplicate in a 25-l volume containing diluted first-strand cDNA synthesis, 2ϫ SABiosciences RT 2 qPCR Master Mix, and RNA-free water. A description of the genes so analyzed is provided in Table 1 . Real-time qRT-PCR reactions consisted of: 95°C for 10 min followed by 40 cycles of 95°C (15 s) and 60°C (1 min, at a ramp rate of 1°C/s) with the CFX96 Real-Time PCR (Bio-Rad Laboratories) instrument. Using the CFX Manager software from Bio-Rad, gene expression was extrapolated from a standard curve and normalized for expression of a housekeeping gene, GAPDH.
Statistical analysis
Each experiment was performed in triplicate and repeated three or more times (a total of n Ն 9 experimental determinations). Results are presented as average Ϯ SEM. Unpaired t-test analyses were performed to evaluate the differences between two groups, whereas data from more than two groups (multiple motilin concentrations) were analyzed by one-way ANOVA, followed by Dunnett's test. Prism 5 software (GraphPad Software, San Diego, CA) was used to prepare graphs and statistical analyses. Statistical significance was set as P Ͻ 0.05. Fig. 3 . Acute motilin treatment stimulates fatty acid (FA) uptake and glucose transport in 3T3-L1 adipocytes. 3T3-L1 adipocytes were differentiated and then treated acutely with indicated motilin concentrations or insulin (50 nM) for 1 h prior to assay of fluorescent BODIPY-FA uptake and incorporation. A: real-time uptake over 2 h for CTL (OE), 1.0 nM motilin (), and 50 nM insulin (boxes). B: (3T3-L1 adipocytes) and D (primary rat adipocytes): area under the curve (AUC), where CTL is set to 100%. C: 2-deoxy- [ 3 H]glucose transport (3T3-L1 adipocyte). Results are presented as average Ϯ SE. Significant differences were analyzed by t-test (insulin) or by ANOVA (motilin), where *P Ͻ 0.05 and **P Ͻ 0.01. For motilin, concentration-dependent effects (ANOVA) were demonstrated for FA uptake (P ϭ 0.0022) and glucose transport (P ϭ 0.01).
RESULTS
Motilin Affects 3T3-L1 Preadipocyte Functions
As presented in Fig. 1A , treatment with motilin significantly stimulated proliferation (P Ͻ 0.05) in a concentration-dependent manner at 0.1, 0.5, 1, and 5 nM vs. CTL in 3T3-L1 preadipocytes. These effects were comparable to IGF-I, a known stimulator of proliferation (14 Ϯ 9%, P Ͻ 0.001). Evaluation of mitochondrial activity was also tested, as shown in Fig. 1B , where insulin (considered as a positive control) increased mitochondrial activity by 265 Ϯ 34% vs. CTL (P Ͻ 0.001). Similarly, motilin significantly (P Ͻ 0.001) increased the mitochondrial activity in a concentration-dependent manner (range: 0.1 to 5 nM). Note: these concentrations of motilin are within the peptide's normal physiological range (0.05 to 0.2 nM) (12, 16) .
Chronic Motilin Treatment During Differentiation Increases Lipid Accumulation and Gene Expression in Adipocytes
As shown in Fig. 2A , Oil red O staining revealed that in 3T3-L1 adipocytes the accumulation of intracellular lipids was significantly enhanced (Fig. 2B ) in a concentration-dependent manner (P ϭ 0.009, linear trend),following chronic supplementation during differentiation with motilin vs. standard differentiation protocol (maximal increase 191 Ϯ 27%, P Ͻ 0.05). Furthermore, the results indicated that 1 nM motilin increased the gene expression of two markers of adipocyte differentiation, peroxisome proliferator-activated receptor-␥ (PPAR␥; 148 Ϯ 8%, P Ͻ 0.01) and CCAAT/enhancer-binding protein-␣ (C/EBP␣; 142 Ϯ 17%, P Ͻ 0.05), along with a lipid raft protein, caveolin-3 (Cav-3), involved in FA and glucose transport, (166 Ϯ 20% P Ͻ 0.05). However, long-term treatment with motilin did not significantly influence the expression of DGAT1 (diacylglycerol acetyltransferase-1) or FABP4 (fatty acid-binding protein-4) over and above the standard differentiation protocol in mature 3T3-L1 adipocytes, as illustrated in Fig. 2C .
Motilin Stimulates Fatty Acid and Glucose Uptake in Adipocytes
The effects of motilin on mature adipocyte functions such as substrate utilization and release were also evaluated. Real-time FA uptake over 2 h for CTL, 1.0 nM motilin and 50 nM insulin are shown in Fig. 3A . As depicted in Fig. 3B , FA uptake and incorporation into lipids in 3T3-L1 mature adipocytes were significantly stimulated (P Ͻ 0.004 ANOVA) following short term treatments (1 h) at both concentrations of motilin (0.1 nM: 175 Ϯ 18%, P Ͻ 0.05; 1.0 nM: 202 Ϯ 12%, P Ͻ 0.01). Similarly, glucose uptake (Fig. 3C ) was significantly (P Ͻ 0.05) increased in 3T3-L1 cells treated with 1 nM motilin. The effects of motilin on both FA uptake and glucose transport were comparable to the effects of insulin, a known positive stimulator of these processes in adipocytes (FA uptake: 223 Ϯ 40%, P Ͻ 0.01, Fig. 3 , A and B; glucose uptake: 159 Ϯ 10%, P Ͻ 0.01, Fig. 3C ). Additionally, 1.0 nM motilin significantly increased FA uptake and incorporation into lipid in primary rat adipocytes by 142 Ϯ 8%, P Ͻ 0.05 (Fig. 3D) . As with the Fig. 4 . Acute motilin treatment stimulates FA reesterification but not lipolysis in 3T3-L1 adipocytes. 3T3-L1 adipocytes were differentiated and then treated acutely with indicated motilin concentrations, insulin (50 nM)or isoproterenol (10 M) or motilin plus insulin for 3 h. Release of NEFA from both 3T3-L1 adipocytes (A) and rat adipose tissue (C) and glycerol release from 3T3-L1 adipocyte (B) and rat adipose tissue (D) were measured in culture medium. Results are presented as average Ϯ SE. Significant differences were analyzed by t-test (insulin, isoproterenol) or by ANOVA (motilin), where *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001. For motilin, concentration-dependent effects (ANOVA) were demonstrated for FA release (P ϭ 0.009) with no significant effects of motilin on glycerol release. 3T3-L1 adipocytes, the effects were comparable to but not additive to insulin (50nM).
Motilin Decreases NEFA Release, But Not Glycerol, in Adipocytes
Intracellular hydrolysis of stored TG results in the release of both NEFA and the glycerol backbone. Both were assessed following a 3-h treatment with motilin. As presented in Fig. 4A , motilin significantly decreased the release of NEFA (maximal effect Ϫ31 Ϯ 11%, P Ͻ 0.05), with a significant dose effect (P ϭ 0.009). The effects of motilin on NEFA release (Fig. 4A ) are comparable to those of insulin (Ϫ39 Ϯ 13%, P Ͻ 0.01). Interestingly, there was no significant impact of motilin on glycerol release (Fig. 3B) , although the known positive stimulant of lipolysis, isoproterenol, was effective (294 Ϯ 34%, P Ͻ 0.01). Furthermore, in rat adipose tissue, treatment with 1.0 nM motilin decreased NEFA release by Ϫ42% (P Ͻ 0.05), comparable to insulin at 50 nM (Ϫ61%, P Ͻ 0.05), although there was no additive effect of insulin plus motilin (Fig. 4C ). There was no significant effect of motilin on glycerol release in rat adipose tissue (Fig. 4D) . With intracellular triglyceride (TG) lipolysis, FAs and glycerol are released at a fixed molar ratio, and any change in NEFA/glycerol ratio indicates a reutilization of the FAs for reesterification to TG (glycerol is not reutilized in the adipocytes). The present observations indicate that motilin displays antilipolytic properties primarily through the stimulation of FA uptake and esterification to TG.
Motilin Affects Adiponectin Secretion and Gene Expression
Following 24-h treatment, motilin significantly decreased adiponectin secretion from mature 3T3-adipocytes compared with control ( Fig. 5A, P Ͻ 0.05) . Interestingly, 1.0 nM motilin significantly decreased adiponectin mRNA expression at both Mature adipocytes were treated with or without motilin for 24 h. A: adiponectin secretion was evaluated in cell culture medium. Adiponectin (B) and adipocyte genes (C) mRNA expression were evaluated by RIA and RT-qPCR, respectively. B: sdiponectin mRNA expression after 9-day incubation with motilin during differentiation is also presented. Results are presented as average Ϯ SE, where significant differences were analyzed by t-test. *P Ͻ 0.05, **P Ͻ 0.01. Human subcutaneous and omental adipose tissue gene expression of MOTR (GPR38), GHSR1, and adiponectin as well as plasma parameters (HOMA) were evaluated by microarray in nonobese and obese men and women (for details see Refs. 22, 23) . Results are presented individually for subcutaneous (OE) and omental () with linear regression analysis as indicated.
24 h (Ϫ25%, P Ͻ 0.05) and 9 days (Ϫ23%, P Ͻ 0.05) (Fig.  5B) . Over this same time period of 24 h, motilin stimulated mRNA expression of PPAR␥ (49%, P Ͻ 0.01), C/EBP␣ (48%, P Ͻ 0.001), C/EBP␤ (255%, P Ͻ 0.01), DGAT1 (30%, P Ͻ 0.01), CD36 (98%, P Ͻ 0.001), and FABP4 (81%, P Ͻ 0.001) (Fig. 5C ). Furthermore, in human adipose tissue, expression of motilin receptor GPR38 correlated with HOMA-IR and GHSR1 (Fig. 5, D and E) , as well as adiponectin expression (Fig. 5F ) and a number of genes involved in lipid and glucose metabolism and insulin signaling such as GLUT4 (data not shown).
Motilin Direct Binding Curve and Competition Binding
To elucidate preliminary mechanisms for motilin action, evaluation of motilin binding and competition was performed in adipocytes. As shown in Fig. 6A, binding (Fig. 6) . Similarly, erythromycin, a motilin agonist (20) , also effectively competes for motilin binding (Fig.  6B) . Given the close similarity between GPR38 and GHSR1 protein sequences in humans and the close correlation in human adipose tissue (Fig. 5E) , we evaluated the capacity of [D-lys3]-GRP6, a GHSR1 antagonist (37) . As shown in Fig.  6B , the antagonist also effectively competed for motilin binding.
Motilin Action on Fatty Acid Uptake and Incorporation Can Be Blocked
As shown in Fig. 6C , erythromycin, a GPR38 agonist, significantly increases FA uptake (129 Ϯ 17%, P Ͻ 0.05) compared with control. While motilin alone stimulated basal FA uptake as expected, pretreatment with MB10 had no effect alone, and completely prevented the effect of motilin on FA uptake (107 Ϯ 15%, P Ͻ 0.05). The GHSR1 antagonist [D-lys3]-GRP6 was also able to block the motilin effect on FA uptake. Furthermore, pretreatment of mature 3T3-L1 adipocytes with wortmannin, a PI 3-kinase inhibitor, prevented motilin from stimulating FA uptake and incorporation, although wortmannin alone had no effect (Fig. 6C ).
DISCUSSION
Although motilin was isolated almost 40 years ago, limited information is presently available regarding its metabolic functions other than direct gastrointestinal effects. Peptide and receptor sequences of motilin and the more recently discovered ghrelin share a high degree of homology. Also, their common cosecretion patterns in the pre-meal condition, their positive effects on food intake (9, 11) , and their prokinetic effects in the gut are indicative that further common regulatory functions might be displayed by the two hormones. The influence of ghrelin on adipocyte functions has already been addressed (26) , but there is presently little or no such information available for motilin. The present results are the first to show that motilin, at physiologically relevant concentrations, positively modulates proliferation and mitochondrial activity in preadipocytes along with adipocyte differentiation as well as substrate (FA and glucose) storage in mature adipocytes.
In mice, although it is still debated whether or not native GPR38 (motilin receptor) is expressed (15) , central administrations of motilin and GM-109 (a motilin antagonist) were respectively shown to increase food intake and reduce anxiety (1, 27) . These and numerous other studies suggest that rodents are a useful model for motilin studies. Taken together, these elements suggest that the 3T3-L1 is a valid model to study the effects of motilin in both preadipocytes and mature adipocytes. Results are presented as average Ϯ SE, where significant differences were analyzed by t-test *P Ͻ 0.05, **P Ͻ 0.01 vs. CTL; ⌽significant difference vs. motilin alone.
Previous reports had indicated that gastrointestinal peptides such as acylated and unacylated ghrelin might influence preadipocyte proliferation (50) . However, such a contribution of motilin has never been addressed. Our present results are the first to show that motilin can stimulate both cell proliferation and mitochondrial activity in 3T3-L1 preadipocytes. Proliferative effects of motilin had been observed previously in pig T lymphocytes (35) but not in rabbit enteric smooth muscle cells (44) . The results obtained here are the first to provide evidence for increased 3T3-L1 preadipocyte production of formazan, suggesting that motilin could stimulate cell mitochondrial activity through the activation of mitochondrial functions. Interestingly, the presence of motilin binding sites had been reported in mitochondrial fractions of colonic smooth muscle (45) , indicating that the peptide might act at extra-and/or intracellular levels.
Differentiation is a critical process by which preadipocytes are converted into mature lipid droplet-accumulating adipocytes (13) . It had been previously reported that peptides such as acylated and unacylated ghrelin could enhance preadipocyte differentiation (26) . The present data indicate that chronic supplementation of differentiating adipocytes with motilin increases lipid accumulation and alters expression of PPAR␥ and C/EBP␣, factors that are involved in adipocyte differentiation (19) . We also demonstrate that motilin receptor is expressed in human adipose tissue and correlates with expression of genes related to lipid and glucose metabolism, insulin signaling, and HOMA (an index of insulin sensitivity).
Furthering the positive effects of motilin supplementation on adipocyte differentiation, the peptide also acutely enhances mature adipocyte functions in 3T3-L1 differentiated cells, as well as primary rat adipocytes and rat adipose tissue, through increased FA uptake, glucose transport, and reesterification without affecting lipolysis (glycerol release). These observations are in line with the only other report found in the literature on motilin adipocyte effects, suggesting that motilin does not stimulate lipolysis in cultured human adipocytes (33) . These functional effects are also consistent with the increases in gene expression of CD36, FABP4, and DGAT1, factors involved in FA uptake and esterification. Results from direct binding assays and competition binding suggest that motilin interacts with a specific receptor, an interaction that can be blocked with a motilin antagonist MB10 (31) or [D-lys3]-GRP6 (37) . Furthermore, the mimicking of the motilin effect with erythromycin and the blocking of the functional effect with antagonists MB10 and [D-lys3]-GRP6 suggest that the motilin effect is mediated via a receptor similar to GHSR1 or GPR38. The signaling pathway includes activation of PI 3-kinase (as this is blocked with wortmannin), again consistent with the signaling pathway activated by both the motilin receptor and the GHSR1 receptor.
It had previously been suggested that circulating motilin could stimulate the postprandial release of insulin via cholinergic muscarinic pathways in dogs (38, 39) and, therefore, enhance FA and glucose uptake while reducing lipolysis. However, our present studies suggest that additional mechanisms might exist whereby motilin could act directly on adipocyte functions and, therefore, play a still undefined role in the development and evolution of obesity in humans. Although the present investigation was conducted in vitro, it provides supporting evidence that, similarly to ghrelin, motilin could be a potent stimulator of energy storage in adipocytes.
